Refobacin骨水泥R（110034355）
K号: K254107 · 2026-04-15
广告
决定日期2026-04-15
产品代码LOD
咨询委员会OR
请注意，由于原文中未提供具体的医疗设备监管文本，以下是一个示例翻译，您可以根据实际文本进行调整：
---
产品名称：[产品名称]
公司名称：[公司名称]
根据FDA 510(k)预市场批准程序，[产品名称]已获得批准，用于[产品用途描述]。
产品注册号：[注册号]
PMA编号：[PMA编号]
临床试验编号（NCT）：[NCT编号]
PubMed ID（PMID）：[PMID编号]
更多信息请访问以下链接：
[URL]
---
请将上述示例中的[产品名称]、[公司名称]、[注册号]、[PMA编号]、[NCT编号]、[PMID编号]和[URL]替换为实际的文本内容。
决定实质等同
器械摘要
Refobacin Bone Cement R (110034355) is the device name listed in this FDA 510(k) record. The listed applicant is Biomet France. It received FDA 510(k) clearance on 2026-04-15 under 510(k) number K254107. The device is classified under product code LOD. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the Refobacin Bone Cement R (110034355)?
Refobacin Bone Cement R (110034355) is a medical device that received FDA 510(k) clearance on 2026-04-15. The listed applicant is Biomet France. The 510(k) number is K254107.
When did Refobacin Bone Cement R (110034355) receive FDA 510(k) clearance?
Refobacin Bone Cement R (110034355) received FDA 510(k) clearance on 2026-04-15, under 510(k) number K254107.
Who is the listed applicant for Refobacin Bone Cement R (110034355)?
The FDA 510(k) record lists Biomet France as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Refobacin Bone Cement R (110034355)?
The FDA product code for Refobacin Bone Cement R (110034355) is LOD.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
相关器械（代码：LOD）
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
K250760SPECTRUM GV骨水泥Osteoremedies, LLCK241674OSTEOPAL® VHeraeus Medical GmbHK231556SPECTRUM® GV骨水泥Osteoremedies, LLCK211163骨水泥 Genta，骨水泥 HV，骨水泥 LVTecres S.P.A.K212729骨水泥-正常粘度Biomecanica Industria E Comerciode Produtos Ortopedicos LtdaK211869OGM 1 聚甲基丙烯酸甲酯 (PMMA) 骨水泥，OGM 1A 聚甲基丙烯酸甲酯 (PMMA) 骨水泥Ormed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告